Page last updated: 2024-08-21

diphenylamine and ku 0063794

diphenylamine has been researched along with ku 0063794 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beale, GS; Haagensen, EJ; Kyle, S; Maxwell, RJ; Newell, DR	1

Other Studies

1 other study(ies) available for diphenylamine and ku 0063794

Article	Year
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition. British journal of cancer, 2012, Apr-10, Volume: 106, Issue:8 Topics: Benzamides; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphenylamine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Imidazoles; Indazoles; Mitogen-Activated Protein Kinase Kinases; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Quinolines; Signal Transduction; Structure-Activity Relationship; Sulfonamides; TOR Serine-Threonine Kinases	2012

Article

Year

The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition.

British journal of cancer, 2012, Apr-10, Volume: 106, Issue:8

Topics: Benzamides; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphenylamine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Imidazoles; Indazoles; Mitogen-Activated Protein Kinase Kinases; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Quinolines; Signal Transduction; Structure-Activity Relationship; Sulfonamides; TOR Serine-Threonine Kinases

2012